The Evolving Clinical Management of Hypertension

Journal of Clinical Hypertension

Volumn 16, Issue 12, 2014, Pages 917-924

  Weber, Michael A ^a  

^a Downstate Health Sciences University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; SPIRONOLACTONE; THIAZIDE DIURETIC AGENT;

ANXIETY; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; BODY MASS; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CHILD HEALTH CARE; CHRONIC KIDNEY DISEASE; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG INDICATION; EDITORIAL; EDUCATION PROGRAM; ELECTRONIC MEDICAL RECORD; ETHNICITY; FRAMINGHAM RISK SCORE; GOOD CLINICAL PRACTICE; HEALTH CARE ACCESS; HEALTH CARE AVAILABILITY; HEALTH CARE PLANNING; HEALTH CARE POLICY; HEALTH CARE QUALITY; HEART INFARCTION; HOME CARE; HUMAN; HYPERTENSION; LOW DRUG DOSE; MEDICAL LITERATURE; MEDICATION COMPLIANCE; OBESITY; PATIENT EDUCATION; PATIENT MONITORING; PATIENT REFERRAL; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; SALT INTAKE; SEX DIFFERENCE; SOCIAL NETWORK; SODIUM INTAKE; SYSTOLIC BLOOD PRESSURE; TREATMENT RESISTANT HYPERTENSION; TREATMENT RESPONSE; WEIGHT REDUCTION; WHITE COAT HYPERTENSION;

HUMANS; HYPERTENSION;

EID: 84919650867     PISSN: 15246175     EISSN: 17517176     Source Type: Journal    
DOI: 10.1111/jch.12444     Document Type: Editorial

References (57)

1. Moser M, Roccella EJ. The treatment of hypertension: a remarkable success story. J Clin Hypertens (Greenwich). 2013;15:88-91.
2. Roccella EJ, Ward G. The national high blood pressure education program: a description of its utility as a generic program model. Health Educ Q. 1984;11:225-242.
3. Weber MA, Oparil S. The human side of failed hypertension treatment. J Clin Hypertens (Greenwich). 2013;15:762-764.
4. Schmieder RE, Grassi G, Kjeldsen SE. Patients with treatment resistant hypertension report increased stress and anxiety: a worldwide study. J Hypertens. 2013;31:610-615.
5. Olomu AB, Gourineni V, Huang JL, et al. Rate and predictors of blood pressure control in a federal qualified health center in Michigan: a huge concern? J Clin Hypertens (Greenwich). 2013;15:254-263.
6. Centers for Disease Control (CDC). Vital signs: prevalence, treatment, and control of hypertension-United States, 1999-2002 and 2005-2008. MMWR Morb Mortal Wkly Rep. 2011;60:103-108.
7. Egan BM, Zhao Y. Different definitions of prevalent hypertension impact: the clinical epidemiology of hypertension and attainment of healthy people goals. J Clin Hypertens (Greenwich). 2013;15:154-161.
8. Fields LE, Burt VL, Cutler JA, et al. The burden of adult hypertension in the United States 1999 to 2000. A rising tide. Hypertension. 2004;44:398-404.
9. Weber MA, Schiffrin EL, White WB, et al. Clinical practice guidelines for the management of hypertension in the community: a statement by the American Society of Hypertension and the International Society of Hypertension. J Clin Hypertens (Greenwich). 2014;16:14-26.
10. Lim NK, Lee KS, Park HY, et al. Predicting the risk of incident hypertension in a Korean middle aged population: Korean genome and epidemiology study. J Clin Hypertens (Greenwich). 2013;15:344-349.
11. Kivimaki M, Batty GD, Singh-Manoux A, et al. Validating the framingham hypertension risk score: results from the Whitehall II Study. Hypertension. 2009;54:496-501.
12. Shah NR, Hirsch AG, Zacker C, et al. Predictors of first-fill adherence for patients with hypertension. Am J Hypertens. 2009;22:392-396.
13. Grigoryan L, Pavlik VN, Hyman DJ. Patterns of non-adherence to antihypertensive therapy in primary care. J Clin Hypertens (Greenwich). 2013;15:107-111.
14. Phillips LS, Branch WT, Cook CB, et al. Clinical inertia. Ann Intern Med. 2001;135:825-834.
15. Desai N, Saraswathy VM, Hunter K, et al. Prevalence of true therapeutic inertia in blood pressure control in an academic chronic kidney disease clinic. J Clin Hypertens (Greenwich). 2013;15:375-379.
16. Abraham I, Camp YV, Villa L. Hierarchical modeling of patient and physician determinants of blood pressure outcomes in adherent vs non-adherent hypertensive patients: pooled analysis of 6 studies with 14, 646 evaluable patients. J Clin Hypertens (Greenwich). 2013;15:663-673.
17. Vrijens B, Vincze G, Kristanto P, et al. Adherence to prescribed antihypertensive drug treatments: longitudinal study of electronically compiled dosing histories. Br Med J. 2008;336:1114-1117.
18. Harle CA, Harman JS, Yang S. Physician and patient characteristics associated with clinical inertia in blood pressure control. J Clin Hypertens (Greenwich). 2013;15:820-824.
19. Okonofua EC, Simpson KN, Jesri A, et al. Therapeutic inertia is an impediment to achieving the healthy people 2010 blood pressure control goals. Hypertension. 2006;47:345-351.
20. Carter BL, Ardery F, Dawson JD, et al. Physician and pharmacist collaboration to improve blood pressure control. Arch Intern Med. 2009;169:1996-2002.
21. Chen Z, Ernst ME, Ardery G, et al. Physician-pharmacist co-management and 24-hour blood pressure control. J Clin Hypertens (Greenwich). 2013;15:337-343.
22. Harrison TN, Ho TS, Handler J, et al. A randomized controlled trial of an automated telephone intervention to improve blood pressure control. J Clin Hypertens (Greenwich). 2013;15:650-654.
23. Glynn LG, Murphy AW, Smith SM, et al. Interventions used to improve control of blood pressure in patient with hypertension. Cochrane Database Syst Rev. 2010;3:CD005182.
24. Centers for Disease Control and Prevention. CDC health disparities and inequalities report. MMWR Surveill Summ. 2011;60(suppl):1-116.
25. Shaya FT, Chirikov VV, Mullins CD, et al. Social networks help control hypertension. J Clin Hypertens (Greenwich). 2013;15:34-40.
26. Agarwal R, Bills JE, Hecht TJW, et al. Role of home blood pressure monitoring in overcoming therapeutic inertial and improving hypertension control: a systematic review and meta-analysis. Hypertension. 2011;57:29-38.
27. Tirabassi J, Fang J, Ayala C. Attitudes of primary care providers and recommendations of home blood pressure monitoring-DocStyles, 2010. J Clin Hypertens (Greenwich). 2013;15:224-229.
28. Hersh WR, Hickam DH, Severance SM, et al. Telemedicine for the Medicare Population Update. Rockville: Agency for Healthcare Research and Quality; 2006.
29. Bowen ME, Bosworth HB, Roumie CL. Blood pressure control in a hypertension telemedicine intervention: does distance to primary care matter? J Clin Hypertens (Greenwich). 2013;15:723-730.
30. Gradman AH, Basile JN, Carter BL, et al. Combination therapy in hypertension. J Am Soc Hypertens. 2010;4:42-50.
31. Handler J. Commentary in support of a highly effective hypertension treatment algorithm. J Clin Hypertens (Greenwich). 2013;15:874-877.
32. Valderrama AL, Gillespie C, King SC, et al. Vital signs: awareness and treatment of uncontrolled hypertension among adults - United States, 2003-2010. MMWR Morb Mortal Wkly Rep. 2012;61:703-709.
33. Cohen DL, Townsend RR. High rates of uncontrolled blood pressure in the United States: does this represent a missed opportunity for healthcare providers? J Clin Hypertens (Greenwich). 2013;15:143.
34. Aburto NJ, Ziolkovska A, Hooper L, et al. Effect of lower sodium intake on health: systematic review and meta-analyses. BMJ. 2013;346:s1326.
35. World Health Organization. WHO Guideline: Sodium Intake for Adults and Children. Report. Geneva, Switzerland: WHO Press;2012:i-46.
36. Campbell NRC, Lackland DT, MacGregor GA. Dietary sodium: a perspective on recent sodium evidence - its interpretation and controversies. J Clin Hypertens (Greenwich). 2013;15:765-768.
37. Trials of Hypertension Prevention Collaborative Research Group. Effects of weight loss and sodium reduction intervention on blood pressure and hypertension incidence in overweight people with high-normal blood pressure. Arch Intern Med. 1997;157:657-667.
38. Tyson CC, Appel LJ, Vollmer WM, et al. Impact of 5-year weight change on blood pressure: results from the Weight Loss Maintenance Trial. J Clin Hypertens (Greenwich). 2013;15:458-464.
39. Thompson M, Dana T, Bougatsos C, et al. Screening for hypertension in children and adolescents to prevent cardiovascular disease. Pediatrics. 2013;131:490-525.
40. Samuels JA, Bell C, Flynn JT. Screening children for high blood pressure: where the US Preventive Services Task Force went wrong. J Clin Hypertens (Greenwich). 2013;15:526-527.
41. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The fourth report on the diagnosis, evaluation and treatment of high blood pressure in children and adolescents. Pediatrics. 2004;114(suppl 2):555-576.
42. Becton LJ, Egan BM, Hailpern SM, et al. Blood pressure reclassification in adolescents based on repeat clinic blood pressure measurements. J Clin Hypertens (Greenwich). 2013;15:717-722.
43. Nelson MR, Quinn S, Bowers-Ingram L, et al. Cluster randomized controlled trial of oscillometric vs manual sphygmomanometer for blood pressure management in primary care. Am J Hypertens. 2009;22:598-603.
44. Eliasdottir SB, Steinthorsdottir MD, Olafur S, et al. Comparison of aneroid and oscillometric blood pressure measurements in children. J Clin Hypertens (Greenwich). 2013;15:776-783.
45. Flynn JT. Assessment of blood pressure in children: it's all in the details. J Clin Hypertens (Greenwich). 2013;15:772-773.
46. Koebnick C, Black MH, Wu J, et al. The prevalence of primary pediatric prehypertension and hypertension in a real-world managed care system. J Clin Hypertens (Greenwich). 2013;15:784-792.
47. Genovesi S, Giussani M, Pieruzzi F, et al. Results of blood pressure screening in a population of school aged children in a province of Milan: role of overweight. J Hypertens. 2005;23:493-497.
48. Koebnick C, Black MH, Wu J, et al. High blood pressure in overweight and obese youth: implications for screening. J Clin Hypertens (Greenwich). 2013;15:793-805.
49. Obarzanek E, Wu CO, Cutler JA, et al. Prevalence and incidence of hypertension in adolescent girls. J Pediatric. 2010;157:461-467.
50. Gu Q, Burt VL, Dillon CF, et al. Trends in antihypertensive medication use and blood pressure control among Unites States adults with hypertension. The National Health and Nutrition Examination Survey, 2001 to 2010. Circulation. 2012;126:2105-2114.
51. Dave GJ, Bibeau DL, Schulz MR, et al. Predictors of uncontrolled hypertension in the Stroke Belt. J Clin Hypertens (Greenwich). 2013;15:562-569.
52. Harman J, Walker ER, Charbonneau V, et al. Treatment of hypertension among African Americans: the Jackson Heart Study. J Clin Hypertens (Greenwich). 2013;15:367-374.
53. Flack JM, Sica DA. Therapeutic considerations in the African American patient with hypertension: considerations with calcium channel blocker therapy. J Clin Hypertens (Greenwich). 2005;7:9-14.
54. Denker MG, Haddad DB, Townsend RR, et al. Blood pressure control 1 year after referral to a hypertension specialist. J Clin Hypertens (Greenwich). 2013;15:624-629.
55. Laragh JH. Vasoconstriction-volume analysis for understanding and treating hypertension: the use of renin and aldosterone profiles. Am J Med. 1973;55:261-274.
56. Roberie DR, Elliott WJ. What is the prevalence of resistant hypertension in the United States? Curr Opin Cardiol. 2012;27:386-391.
57. Elliott WJ, Egan B, Giles TD, et al. Rationale for establishing a mechanism to increase reimbursement to hypertension specialists. J Clin Hypertens (Greenwich). 2013;15:397-403.